Ratnakar Securities Pvt. Ltd.

THYROCARE TECHNOLOGIES LTD.

NSE : THYROCAREBSE : 539871ISIN CODE : INE594H01019Industry : Hospital & Healthcare ServicesHouse : MNC

BSE651.70-10.3 (-1.56 %)

PREV CLOSE ( ) 662.00

OPEN PRICE ( ) 660.10

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 5033

TODAY'S LOW / HIGH ( )648.95 666.20

52 WK LOW / HIGH ( )432.05 722

BSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 28-01 2000

Management Info

- Chairman - Managing Director

Registered Office

Address D - 37/1, T T C Industrial Area,M I D C,Turbhe,
Navi Mumbai,
Maharashtra-400703

Phone 022 3090 0000 / 2762 2762

Email investor_relations@thyrocare.com / enquiry@thyrocare.com

Website www.thyrocare.com

Registrars Details

Link Intime India Pvt Ltd.

C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai

Listing : BSE, NSE

NEWS

28Feb Torrent Power, Infosys and UGRO Capita
Torrent Power has emerged as the Successful Bidder and has received Lett..

28Feb Thyrocare Technologies completes acqui
Thyrocare Technologies has completed the acquisition by way purchase of..

28Feb Thyrocare Technologies jumps on comple
Thyrocare Technologies is currently trading at Rs. 717.15, up by 75.35 p..

23Feb Thyrocare Technologies informs about a
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosur..

01Feb Thyrocare Technologies to acquire 100%
Thyrocare Technologies has entered into a Share Purchase Agreement with..

Financials

in Millions

	QTR Dec 23	ANNUAL 23
Net Profit	148.9	569.7
Gross Profit	207.6	810.7
Operating Profit	326.2	1174
Net Sales	1228.9	4864.6

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Dr Agarwals Eye Hsp (BSE) 3564.55 (2.56%)	M.Cap ( in Cr)1675.34
Dr. Lal Pathlabs (BSE) 2387.05 (2.45%)	M.Cap ( in Cr)19926.58
Kovai Medical Center (BSE) 4193.40 (1.09%)	M.Cap ( in Cr)4588.53
RainbowChildrenS Med (BSE) 1343.85 (2.13%)	M.Cap ( in Cr)13640.30
Metropolis Health. (BSE) 1805.55 (0.76%)	M.Cap ( in Cr)9249.62

Shareholding Pattern

	PROMOTERS	71.11%
	MUTUAL FUNDS/UTI	12.94%
	NON-INSTITUTION	11.1%
	FI/BANKS/INSURANCE	1.08%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
HDFC Pharma and Hea...	2.57
Nippon India Pharma...	1.46
ICICI Pru Pharma He...	1.20
ICICI Pru Innovatio...	0.63
Nippon India Retire...	0.63
ICICI Pru Bharat Co...	0.60

attention investors
kyc
ipo
ibt trading

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

Ratnakar Securities

Smart Quotes

THYROCARE TECHNOLOGIES LTD.

Filing complaints on SCORES Easy & quick

RISK DISCLOSURES ON DERIVATIVES